Using next-generation sequencing to identify biomarkers in CML
Have novel drugs made stem cell transplantation obsolete?
COMy 2016: Highlights from Day 2
Arnon Nagler et al.
Topics in multiple myeloma discussed at ASCO 2016
The main prognostic factors and why minimal residual disease is becoming crucial in multiple myeloma